The DOI matches its Crossref record.
Hypertriglyceridemic Waist: A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?
Abstract
Background —The present study tested the hypothesis that simple variables, such as waist circumference and fasting plasma triglyceride (TG) concentrations, could be used as screening tools for the identification of men characterized by a metabolic triad of nontraditional risk factors (elevated insulin and apolipoprotein [apo] B and small, dense LDL particles). Methods and Results —Results of the metabolic study (study 1) conducted on 185 healthy men indicate that a large proportion (>80%) of men with waist circumference values ≥90 cm and with elevated TG levels (≥2.0 mmol/L) were characterized by the atherogenic metabolic triad. Validation of the model in an angiographic study (study 2) on a sample of 287 men with and without coronary artery disease (CAD) revealed that only men with both elevated waist and TG levels were at increased risk of CAD (odds ratio of 3.6, P <0.03) compared with men with low waist and TG levels. Conclusions —It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting TG could be used as inexpensive screening tools to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apo B, small, dense LDL) and at high risk for CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adding biochemical markers, such as plasma triglyceride levels, to the measurement of waist circumference—a phenotype described as hypertriglyceridaemic waist—has been suggested as a useful method for identification of individuals with excess visceral adipose tissue and ectopic fat.51”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1073/pnas.77.1.604 · DOI
- 10.1161/circ.94.3.273 · DOI
- 10.1136/hrt.71.3.293 · DOI
- 10.1056/NEJM199604113341504 · DOI · Paper page
- 10.1161/atv91.12.2.1543692 · DOI
- 10.1161/circ.95.1.69 · DOI
- 10.1001/jama.279.24.1955 · DOI
- 10.2337/diab.41.7.826 · DOI
- 10.1016/0002-9149(94)90676-9 · DOI
- 10.2337/diacare.19.6.629 · DOI · Paper page
- 10.1093/clinchem/28.10.2077 · DOI
- 10.1093/clinchem/20.4.470 · DOI
- 10.1172/JCI103182 · DOI
- 10.1016/0009-8981(60)90075-9 · DOI
- 10.1016/0003-2697(66)90246-6 · DOI
- 10.1016/0026-0495(87)90183-1 · DOI
- 10.1210/jcem-33-5-732 · DOI
- Standardization of anthropometric measurements. In: Lohman T Roche A Martorel R eds. The Airlie (VA) Consensus Conference. Champaign Ill: Human Kinetics; 1988:39–80.
- 10.1079/BJN19890104 · DOI
- 10.1016/S0002-9149(98)00328-2 · DOI
- 10.1161/circ.97.9.871 · DOI
- 10.1016/0009-8981(87)90188-4 · DOI
- 10.1093/clinchem/28.6.1379 · DOI
- 10.1093/clinchem/18.6.499 · DOI · Paper page
- 10.1161/atv91.12.11.1420088 · DOI
- 10.1161/01.CIR.85.1.37 · DOI · Paper page
- 10.1079/NRR19930010 · DOI
- 10.1016/S0140-6736(94)90814-1 · DOI
Cited by
Sorted by citations
Items 501–600 of 819
PPARα: its role in the human metabolic syndrome
Azhar, S., & Kelley, G. (2007) · Future Lipidology · doi:10.2217/17460875.2.1.31 · Cited by 12
“The reviewers provide a brief chronology in Table 1 detailing the historical developments and the evolution of the nomenclature of the field [80–100].”
BackgroundGender Differences in the Pathogenesis and Management of Heart Disease
Mehta, J., & McSweeney, J. (2018) · Cambridge International Law Journal · doi:10.1007/978-3-319-71135-5 · Cited by 12
Correlación entre las diferentes medidas de obesidad y el grado de resistencia a la insulina
Molist‐Brunet, N., Jimeno-Mollet, J., & Franch‐Nadal, J. (2006) · Atención Primaria · doi:10.1157/13083939 · Cited by 10
Yu, X.-P., Wang, D., Xiao, W.-M., Shi, X., She, Q., Sun, H., Qi, T.-Y., Xu, R., Li, G.-Q., Liu, X.-N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78883-1 · Cited by 11
Shahinfar, H., Akbarzade, Z., Djafari, F., & Shab‐Bidar, S. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00607-z · Cited by 10
Riedl, A., Vogt, S., Holle, R., Gala, T. D. L. H., Laxy, M., Peters, A., & Thorand, B. (2016) · Public Health Nutrition · doi:10.1017/s1368980016001270 · Cited by 10
Ram, J., Snehalatha, C., Nanditha, A., Selvam, S., Shetty, S., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2014) · Diabetic Medicine · doi:10.1111/dme.12517 · Cited by 12
Yajnik, C., Joglekar, C., Chinchwadkar, M. C., Sayyad, M., Deshpande, S., Naik, S., Bhat, D., Ganpule, A., Shetty, P., & Yudkin, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.053 · Cited by 11
Obesity: how to define central adiposity?
Méthot, J., Houle, J., & Poirier, P. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.38 · Cited by 8
Milagros Espinoza, Z., Nelina Ruiz, F., Barrios, E., Reigosa, A., Herrera, U. L., & González, J. C. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000900006 · Cited by 13
Hypertensive Waist: First Step of the Screening for Metabolic Syndrome
Niță, C., Hancu, N., Rusu, A., Bala, C., & Roman, G. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0039 · Cited by 11
“In 2000, Lemieux et al. 21 developed the concept of “hyper-triglyceridemic waist” to identify at low cost high-risk individuals who would likely be carriers of the atherogenic metabolic triad that characterized the metabolic syndrome.”
Okosun, I. S., & Boltri, J. M. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.003 · Cited by 12
Quality as well as quantity? Beyond low-density lipoprotein-cholesterol - the role of particle size*
Wierzbicki, A. S. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01571.x · Cited by 12
Assessment of metabolic profile in a clinical setting
Pervanidou, P., Kanaka‐Gantenbein, C., & Chrousos, G. P. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241669.24923.8d · Cited by 10
Couillard, C., Vohl, M., Engert, J., Lemieux, I., Houde, A., Alméras, N., Prud'homme, D., Nadeau, A., Despres, J., & Bergeron, J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300043-jlr200 · Cited by 11
Self-citationThe Endocannabinoid System as a Target for Obesity Treatment
Aronne, L. J., Pagotto, U., Foster, G. D., & Davis, S. N. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(08)60028-9 · Cited by 9
Assessing nutritional quality as a ‘vital sign’ of cardiometabolic health
Buteau-Poulin, D., Poirier, P., Despres, J., & Alméras, N. (2019) · British Journal of Nutrition · doi:10.1017/s0007114519001016 · Cited by 10
Self-citationYang, R.-F., Zhang, H.-L., Wang, Z.-C., Liu, X.-Y., & Lin, Z. (2018) · Immunity & Ageing · doi:10.1186/s12979-018-0119-6 · Cited by 10
“Additionally, high TG and WP increased the risk of cardiovascular disease [16].”
BackgroundLiver Transplantation: the Role of Metabolic Syndrome
Davis, B., & Siddiqui, M. S. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0135-1 · Cited by 12
Rosolová, H., Nussbaumerova, B., Mayer, O., Cífková, R., & Bruthans, J. (2017) · Physiological Research · doi:10.33549/physiolres.933598 · Cited by 10
“We found no significant difference in the prevalence of hypertriglyceridemic waist (33 % in EUROASPIRE I, 27-29 % in EUROASPIRE II-IV), defined as TG≥2.0 mmol/l and waist circumference ≥90 cm in males and ≥85 cm in females (Lemieux et al. 2000).”
BackgroundInfluentialAn Analysis of Individual Body Fat Depots and Risk of Developing Cancer
Gupta, A., Pandey, A., Ayers, C. R., Beg, M. S., Gilchrist, S. C., Vega, G. L., Grundy, S. M., Johnson, D. H., & Neeland, I. J. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.12.023 · Cited by 13
Anthropometry in cardio-metabolic risk assessment
Mišigoj-Duraković, M., Sorić, M., & Duraković, Z. (2014) · Arhiv za Higijenu Rada i Toksikologiju · doi:10.2478/10004-1254-65-2014-2381 · Cited by 10
Moyle, G., Hardy, H., Farajallah, A., DeGrosky, M., & McGrath, D. (2014) · Clinical drug investigation · doi:10.1007/s40261-014-0175-4 · Cited by 10
Kataria, I., Chadha, R., & Pathak, R. (2013) · Reviews in Health Care · doi:10.7175/rhc.v4i4.667 · Cited by 11
“Other factors include abdominal obesity [21-23], insulin resistance [10,11], along with physical inactivity [22,24], aging [25], hormonal imbalance [26], and atherogenic diet [12].”
BackgroundAkbarzadeh, M., Moradi, F., Dabbaghmanesh, M. H., Jafari, P., & Parsanezhad, M. E. (2013) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2013.10872312 · Cited by 6
Thermogenesis-based interventions for obesity and Type 2 diabetes mellitus
Wimalawansa, S. J. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.13 · Cited by 6
Angiographically-assessed coronary artery disease associates with HDL particle size in women.
Blackburn, P., Lemieux, I., Lamarche, B., Bergeron, J., Perron, P., Tremblay, G., Gaudet, D., & Despres, J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.016 · Cited by 10
Self-citationAntibodies and ABO‐incompatibility in pediatric transplantation
West, L. (2011) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2011.01579.x · Cited by 10
Saunders, T. J., Davidson, L. E., Janiszewski, P. M., Després, J., Hudson, R., & Ross, R. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp079 · Cited by 12
Self-citationDespres, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.27 · Cited by 10
Candela, J. M., Nadal, J. F., Ortiz, J. R., Domínguez, C. C., Martín, A. G., & Yepes, M. L. L. (2007) · Medicina Clínica · doi:10.1157/13111806 · Cited by 10
Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist.
Underwood, P. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137237.97341.fd · Cited by 10
Ware, W. R. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.02.008 · Cited by 12
Dyslipidemia in the metabolic syndrome
Chan, D. C., & Watts, G. F. (2004) · Journal of Drug Evaluation · doi:10.3109/14791130410001728524 · Cited by 10
A machine learning approach to personalized predictors of dyslipidemia: a cohort study
Gutiérrez-Esparza, G. O., Pulido, T., Martínez-García, M., Ramírez-delReal, T. A., Groves-Miralrio, L. E., Márquez-Murillo, M. F., Amezcua-Guerra, L. M., Vargas‐Alarcón, G., & Lemus, E. H. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1213926 · Cited by 12
Gulbahar, A., Çağlar, G., & Arslanca, T. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111986 · Cited by 9
“Considering that male sex is considered an inherent risk factor for CVD, most of these reports included male patients only (Lemieux et al., 2000; Bots et al., 2017; Shaw et al., 2009; Mauvais-Jarvis et al., 2020).”
BackgroundMoreira, V. C., Silva, C. M. S., Welker, A. F., & da Silva, I. C. R. (2022) · Journal of Aging Research · doi:10.1155/2022/8350527 · Cited by 13
Chen, D., Sun, H., Lu, C.-Y., Chen, W.-Q., & Guo, V. (2022) · Scientific Reports · doi:10.1038/s41598-022-05806-7 · Cited by 9
Borges, L. D., Comini, L. D. O., de Oliveira, L. C., Dias, H. H., Ferreira, E. D. S., Batistelli, C. R. S., da Costa, G. D., Moreira, T., Silva, R. D. D., & Cotta, R. M. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.71 · Cited by 9
“HTWP is an effective and less invasive method to identify individuals susceptible to developing CVDs (20) .”
InfluentialDesprés, J. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e11 · Cited by 11
Self-citationSu, W., Wang, J., & Mu, Y. (2020) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s257736 · Cited by 9
Delautre, A., Chantrel, F., Dimitrov, Y., Klein, A., Imhoff, O., Muller, C., Schauder, N., Hannedouche, T., & Krummel, T. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02004-3 · Cited by 9
Ren, Y.-C., Liu, Y., Sun, X.-Z., Wang, B.-Y., Liu, Y., Ni, H., Zhao, Y., Liu, D., Liu, X.-J., Zhang, D.-D., et al. (2019) · Public Health Nutrition · doi:10.1017/s1368980019000181 · Cited by 9
Lipid accumulation product index in HIV-infected patients: a marker of cardiovascular risk
Guimarães, M. M., Greco, D., Moreira, A., Guimarães, N., Freire, C. V., Rohlfs, B. G., & Machado, L. J. D. C. (2018) · Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.03.006 · Cited by 9
Freitas, R. S., da Fonseca, M. D. J. M., Schmidt, M. I., Molina, M. D. C. B., & de Almeida, M. D. C. C. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00067617 · Cited by 18
“Sociodemográficos Grupo etário (anos) 35-44 1,00 * 1,00 * 1,00 * 1,00 * 45-54 1,78 (1,49-2,12) 1,27 (1,03-1,57) 1,81 (1,47-2,22) 1,26 (0,99-1,61) 55-64 2,48 (2,07-2,98) 1,52 (1,16-1,98) 2,50 (2,02-3,10) 1,49 (1,10-2,02) 65-74 2,49 (1,94-3,19) 1,56 (1,12-2,18) 2,79 (2,11-3,69) 1,77 (1,21-2,58) Nível de escolaridade Sup…”
Lee, B. J., Nam, J., & Kim, J. Y. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1024-1 · Cited by 10
“[11] indicated that the combination of WC and the TG level constitutes a simple and inexpensive indicator of the risk of atherogenic metabolic Table 2 Analysis of the associations and powers of models of the HW phenotype and all phenotypes consisting of an individual index with/without the TG level to predict hypercho…”
BackgroundMa, C.-M., Liu, X.-L., Yin, F.-Z., Gao, G.-Q., Wang, R., & Lu, Q. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2522-8 · Cited by 9
Hypertriglyceridemic Waist and Metabolic Abnormalities in Brazilian Schoolchildren
Guilherme, F. R., Molena-Fernandes, C., Hintze, L. J., Fávero, M. T., Cuman, R., & Rinaldi, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111724 · Cited by 9
“That besides being an indicator of visceral obesity and metabolic triad, has been suggested as a predictor of the atherogenic metabolic triad (hyperinsulinemia, elevated apolipoprotein B levels and high concentrations of small and dense low-density lipoprotein (LDLC), and the metabolic syndrome [8,9].”
BackgroundAvramoglu, R. K., Laplante, M., Quang, K. L., Deshaies, Y., Després, J., Larose, É., Mathieu, P., Poirier, P., Përusse, L., Vohl, M., et al. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.262 · Cited by 7
“In order to provide clinicians with simple tools to further refine CVD risk assessment beyond traditional risk factors and blood glucose control, the hypertriglyceridemic waist (hyperTG-waist) phenotype has been proposed (64).”
BackgroundSelf-citationParticular characteristics of the metabolic syndrome in patients with morbid obesity.
Tinahones, F., Garrido-Sanchez, L., Murri, M., García-Fuentes, E., & Cardona, F. (2013) · Endocrinologia y Nutricion · doi:10.1016/j.endonu.2012.09.007 · Cited by 9
Hypertriglyceridemic waist: missing piece of the global cardiovascular risk assessment puzzle?
Arsenault, B. J., Després, J., & Boekholdt, S. M. (2011) · Clinical Lipidology · doi:10.2217/clp.11.51 · Cited by 6
Self-citationThe Effect of Insulin Resistance and Obesity on Low−Density Lipoprotein Particle Size in Children
Taşçılar, M., Özgen, T., Cihan, M., Abacı, A., Yeşilkaya, E., Eker, İ., & Serdar, M. (2010) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v2i2.63 · Cited by 9
Segura, B., & Luque, M. À. J. (2009) · Revista de Neurología · doi:10.33588/rn.4908.2008425 · Cited by 11
Using simple anthropometric measures to predict body fat in South Asians
Kohli, S., Gao, M., & Lear, S. A. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-128 · Cited by 7
“34: 40–48 (2009) doi:10.1139/H08-128 Published by NRC Research Press cardiovascular disease, hypertension, dyslipidemia, psychosocial issues, and a variety of cancers (Engeland et al. 2004; Freedman et al. 2001; Lau et al. 2007; Lemieux et al. 2000).”
BackgroundInfluentialLópez-Alvarenga, J. C., Solis-Herrera, C., Kent, J., Jaju, D., Albarwani, S., Yahayee, S. A., Hassan, M., Bayoumi, R., & Comuzzie, A. G. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0039 · Cited by 9
Metabolic risk-factor clustering estimation in obese children
Bueno, G., Moreno, L. A., Bueno, O. M., Morales, J., Pérez, T., Garagorri, J. M., & Bueno, M. (2007) · Journal of Physiology and Biochemistry · doi:10.1007/bf03165766 · Cited by 12
Examining the metabolic syndrome in Russia.
Jones, E. D., Ivanov, L., Wallace, D., & VonCannon, L. (2006) · International Journal of Nursing Practice · doi:10.1111/j.1440-172x.2006.00579.x · Cited by 9
Complex Cardiometabolic Risk Factors: Impact, Assessment, and Emerging Therapies
Tangalos, E. G., Cota, D., & Fujioka, K. (2006) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2006.06.003 · Cited by 11
Le syndrome métabolique : quelle(s) définition(s) pour quel(s) objectif(s) ?
Eschwège, É. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81732-9 · Cited by 13
Benefits of exercise and dietary measures to optimize shifts in body composition with age
Singh, M. A. F. (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.11.supp3.17.x · Cited by 21
Therapeutic considerations for postprandial dyslipidaemia
Burnett, J. R., & Watts, G. F. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00155.x · Cited by 8
Vaverkova, H., Karásek, D., Novotný, D., Halenka, M., Orság, J., & Slavík, L. (2015) · Physiological Research · doi:10.33549/physiolres.933198 · Cited by 9
“The concept of hypertriglyceridemic waist (HTGW) as a simple phenotype to detect subjects with cardiometabolic risk was suggested 15 years ago by Lemieux et al. (2000).”
BackgroundEl ácido úrico es un predictor de desarrollo de diabetes mellitus tipo 2 en la población general
Cardona, F., Rojo‐Martínez, G., Almaraz, M. C., Soriguer, F., García‐Fuentes, E., & Tinahones, F. J. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)70554-6 · Cited by 8
Bashir, B., Adam, S., Ho, J. H., Linn, Z., Durrington, P. N., & Soran, H. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000889 · Cited by 7
Amadi, C. E., Mbakwem, A. C., Dolapo, D. C., Udenze, I. C., Akinsola, C. M., Ajuluchukwu, J. N., & Oke, D. A. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001203 · Cited by 9
“[9] demonstrated that the hypertriglyceridemic waist (HTGW) phenotype (defined as co-occurring hypertriglyceridemia and elevated WC) was a simple and inexpensive tool to identify cardiometabolic abnormalities (especially the metabolic triad of hyperinsulinemia, elevated Apolipo B and small dense LDL-c) in individuals…”
BackgroundYang, M., Xu, Y.-Q., Hu, C., Zhang, S., Kuang, M.-B., & Zou, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01660-8 · Cited by 8
“, more than 80% of male subjects with the HTGW phenotype had abnormal metabolic characteristics that cause atherosclerosis [13].”
BackgroundMetabolic syndrome in hypertensive and non‐hypertensive subjects
Senarathne, R., Hettiaratchi, U., Dissanayake, N., Hafiz, R., Zaleem, S., & Athiththan, L. (2021) · Health Science Reports · doi:10.1002/hsr2.454 · Cited by 8
“%) subjects in non-hypertensive group presented with MetS.”
BackgroundInfluentialCôté, C., Rhéaume, C., Poirier, P., Despres, J., & Alméras, N. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz087 · Cited by 8
Self-citationSaber, G. Y., Kasabri, V. N., Saleh, M., Suyagh, M. F., Halaseh, L., Jaber, R. M., Abu-Hassan, H. H., & Alalawi, S. (2019) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0063 · Cited by 12
Modifiable Clinical Correlates of Vascular Health in Children and Adolescents with Dyslipidemia
White, D. A., Anand, G. M., Qayum, O., Ibezim, C. F., Sherman, A., & Raghuveer, G. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02071-w · Cited by 9
Fagundes, L. C., Fernandes, M., Brito, T. A., Coqueiro, R. D. S., & Carneiro, J. A. (2018) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232018232.02862016 · Cited by 8
Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study
Hosseini, N., Talaei, M., Dianatkhah, M., Sadeghi, M., Oveisgharan, S., & Sarrafzadegan, N. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0156 · Cited by 6
Karagöz, A., Onat, A., Aydın, M., Can, G., Şimşek, B., & Yüksel, M. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1261608 · Cited by 5
Sakane, N., Dohi, S., Sakata, K., Hagiwara, S.-I., Morimoto, T., Uchida, T., Katashima, M., Yanagisawa, Y., Yasumasu, T., & J-Value Study Group (2013) · ISRN Obesity · doi:10.1155/2013/473764 · Cited by 8
“Indeed, visceral adipose tissue was found to be more strongly linkedwith the risk of hyperlipidemia [10, 11], insulin resistance [12–14], and diabetes [15, 16] than subcutaneous fat.”
BackgroundBernal, E., Marín, I., Muñoz, Á., Sabán, J., Sarabia, F., García-Medina, A., Tomás, V., & Cano, A. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.03.037 · Cited by 6
Racine, N., Hamet, P., Sampalis, J., Longo, N., & Bastien, N. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.3 · Cited by 8
Hong, Y.-M., Song, Y. W., Kim, H., Park, H., Min, J., Jung, J., Kim, N., & Noh, C. (2009) · Korean Journal of Pediatrics · doi:10.3345/kjp.2009.52.10.1109 · Cited by 8
Obesidad intraabdominal y riesgo cardiometabólico
Nadal, J. (2008) · Atención Primaria · doi:10.1157/13118063 · Cited by 8
Perron, P., Brisson, D., Santuré, M., Blackburn, P., Bergeron, J., Vohl, M., Després, J.-P., & Gaudet, D. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346348 · Cited by 8
Self-citationFarnier, M., Garnier, P., Yau, C., Dejager, S., & Verpilleux, M.-P. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01124.x · Cited by 7
The realities of dyslipidaemia in metabolic syndrome and diabetes
Barter, P. J. (2005) · The British Journal of Diabetes · doi:10.1177/1474651405005001s0301 · Cited by 6
Zhang, N., Chao, J., Wu, X., Chen, H., & Bao, M. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.044 · Cited by 6
Dikaiakou, E., Athanasouli, F., Fotiadou, A., Kafetzi, M., Fakiolas, S., Michalacos, S., & Vlachopapadopoulou, E. (2023) · Metabolites · doi:10.3390/metabo13020230 · Cited by 7
Li, B.-Q., Wang, J., Zhou, X., Wang, W.-Q., Gao, Z.-N., Tang, X.-L., Yan, L., Wan, Q., Luo, Z.-J., Qin, G., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01113-w · Cited by 7
Zhou, M., Li, F., Tang, H., Wu, S., Meng, L., Dong, Y.-H., Wang, F., Quach, B., Yang, Y.-D., Ma, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-00825-2 · Cited by 7
Braha, A., Albai, A., Timar, B., Cipu, D., Vasiluță, L., Potre, O., & Timar, R. (2021) · Medicina · doi:10.3390/medicina58010021 · Cited by 7
Namdarimoghaddam, P., Fowokan, A., Humphries, K. H., Mancini, G. B. J., & Lear, S. A. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01882-1 · Cited by 7
Miñambres, I., Sánchez-Hernandez, J., Cuixart, G., Sánchez-Pinto, A., Sarroca, J., & Pérez, A. (2020) · Revista clínica española (Ed. impresa) · doi:10.1016/j.rce.2020.06.013 · Cited by 7
Yu, D.-H., Yang, W., Chen, T., Cai, Y., Zhao, Z.-Z., & Simmons, D. (2018) · Obesity Research and Clinical Practice · doi:10.1016/j.orcp.2018.07.010 · Cited by 7
Taherian, R., Jalali-Farahani, S., Karimi, M., Amiri, P., Maghsoudi, E., Mirmiran, P., & Azizi, F. (2018) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.59706 · Cited by 7
Johnston, L., Liu, Z., Retnakaran, R. R., Zinman, B., Giacca, A., Harris, S. B., Bazinet, R. P., & Hanley, A. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p084970 · Cited by 11
Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points
Braz, M., Vieira, J., Gomes, F. O., da Silva, P. R., Santos, O. T. D. M., da Rocha, I. M. G., de Sousa, I. M., & Fayh, A. P. T. (2017) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s143595 · Cited by 7
“3% in men and 17% in women, using the cutoff point of Lemieux et al.(3,5) In Malaysia, Zainuddin et al(28) evaluated 298 people aged 18–70 years using two different cutoffs for the HTGW phenotype: IDF(24) and NCEP/ATPIII.”
InfluentialEpidemiology of Metabolic Syndrome among Adult Nigerians in a Rural Hospital in Eastern Nigeria
Iloh, G. U. P., Okafor, G. O. C., & NkwaAmadi, A. (2014) · Science Journal of Public Health · doi:10.11648/j.sjph.20140202.23 · Cited by 6
Suhartatik, N., Karyantina, M., & Purwanti, I. T. (2012) · doi:10.22146/agritech.9758 · Cited by 7
Zoeller, R. F. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607304696 · Cited by 6
Evaluation of plasma adiponectin levels in young men with coronary artery disease
Koz, C., Uzun, M., Yokuşoǧlu, M., Baysan, O., Erinc, K., Saǧ, C., Haşimi, A., & Işık, E. (2007) · Acta Cardiologica · doi:10.2143/ac.62.3.2020811 · Cited by 7
Estimated risk of coronary heart disease in obese adult males in Northern Jordan
Alboqai, O. K., Suleiman, A. A., Al‐Natour, M. Q., Al-Hourani, H. M., & Abuirmeileh, N. M. (2006) · Saudi Medical Journal · doi:10.15537/1658-3175.3428 · Cited by 8
Le syndrome métabolique : comparaison des paramètres biologiques dans différentes définitions
Luyckx, F., & Scheen, A. J. (2004) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2004.03.008 · Cited by 6
Hyperlipidaemia and cardiovascular disease.
Kuller, L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-199808000-00014 · Cited by 7
Association of regional adiposity distribution with risk of autoimmune diseases
Fan, R., Zhang, Z.-H., Huang, Q.-L., Liu, L.-Q., Que, W.-J., Lu, D., Jing, S., Gan, Y., Liu, S., & Xiao, F. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07426-8 · Cited by 6
Metadata
- Authors
- Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., Nadeau, A., & Després, J.-P.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- From the Quebec Heart Institute, Laval Hospital Research Center; the Lipid Research Center, CHUL Research Center; the Physical Activity Sciences Laboratory, Laval University; the Diabetes Research Unit, CHUL Research Center, Ste-Foy; and the Lipid Clinic, Chicoutimi Hospital, Chicoutimi, Québec, Canada.
- ORCID
- Venue
- Circulation
- Published
- 2000-07-11
- Volume
- 102
- Issue
- 2
- Pages
- 179-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991251155
- Cited by
- 937
- References
- 0
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 31 · 2021: 29 · 2020: 30 · 2019: 26 · 2018: 35 · 2017: 29 · 2016: 38 · 2015: 38 · 2014: 42 · 2013: 42 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Heart and Stroke Foundation of Canada
- Medical Research Council Canada
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hypertriglyceridemic waist phenotype, waist circumference, fasting plasma triglycerides, hyperinsulinemia, apolipoprotein B, small dense LDL, coronary artery disease risk, cardiovascular screening, men
- MeSH terms
- Abdomen, Adult, Apolipoproteins B, Body Composition, Coronary Artery Disease, Coronary Disease, Humans, Hyperinsulinism, Lipoproteins, LDL, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review